Literature DB >> 18043003

A case-control study of the environmental risk factors for narcolepsy.

Dante Picchioni1, Chris R Hope, John R Harsh.   

Abstract

BACKGROUND: Despite the acknowledged importance of environmental risk factors in the etiology of narcolepsy, there is little research on this topic. This study sought to fill this gap in the literature and assess the risk of stressors and infectious diseases using a case-control study.
METHODS: Cases (n = 63) were recruited through the Stanford Center for Narcolepsy. All were HLA-DQB1*0602 positive, met conventional Multiple Sleep Latency Test criteria, and reported unambiguous cataplexy. Controls (n = 63) were nonrelated family members of cases and local community members. A self-administered questionnaire was used to assess the frequency and timing of possible risk factors.
RESULTS: Of the infectious diseases examined, only flu infections and unexplained fevers carried a significant risk. Several of the stressors carried a significant risk including a major change in sleeping habits. When the timing of all risk factors was considered, exposure prior to puberty increased the risk for developing narcolepsy.
CONCLUSIONS: These findings emphasize the importance of environmental risk factors in the etiology of narcolepsy. This highlights the need for further research on this aspect of narcolepsy so a complete understanding of a disorder that affects 1 in 2,000 individuals can emerge. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043003     DOI: 10.1159/000111581

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  15 in total

1.  Using magnetic resonance spectroscopy in narcolepsy to study the limbic mechanisms of cataplexy.

Authors:  Dante Picchioni
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

Review 2.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 3.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.

Authors:  Yahel Segal; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

4.  Environmental toxins and risk of narcolepsy among people with HLA DQB1*0602.

Authors:  Thanh G N Ton; W T Longstreth; Thomas D Koepsell
Journal:  Environ Res       Date:  2010-06-01       Impact factor: 6.498

Review 5.  Evidence-based recommendations for the assessment and management of sleep disorders in older persons.

Authors:  Harrison G Bloom; Imran Ahmed; Cathy A Alessi; Sonia Ancoli-Israel; Daniel J Buysse; Meir H Kryger; Barbara A Phillips; Michael J Thorpy; Michael V Vitiello; Phyllis C Zee
Journal:  J Am Geriatr Soc       Date:  2009-05       Impact factor: 5.562

Review 6.  Autoimmunity in narcolepsy.

Authors:  Melodie Bonvalet; Hanna M Ollila; Aditya Ambati; Emmanuel Mignot
Journal:  Curr Opin Pulm Med       Date:  2017-11       Impact factor: 3.155

7.  H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice.

Authors:  Chiara Tesoriero; Alina Codita; Ming-Dong Zhang; Andrij Cherninsky; Håkan Karlsson; Gigliola Grassi-Zucconi; Giuseppe Bertini; Tibor Harkany; Karl Ljungberg; Peter Liljeström; Tomas G M Hökfelt; Marina Bentivoglio; Krister Kristensson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

8.  AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.

Authors:  Hanna Nohynek; Jukka Jokinen; Markku Partinen; Outi Vaarala; Turkka Kirjavainen; Jonas Sundman; Sari-Leena Himanen; Christer Hublin; Ilkka Julkunen; Päivi Olsén; Outi Saarenpää-Heikkilä; Terhi Kilpi
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

9.  Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.

Authors:  Markku Partinen; Outi Saarenpää-Heikkilä; Ismo Ilveskoski; Christer Hublin; Miika Linna; Päivi Olsén; Pekka Nokelainen; Reija Alén; Tiina Wallden; Merimaaria Espo; Harri Rusanen; Jan Olme; Heli Sätilä; Harri Arikka; Pekka Kaipainen; Ilkka Julkunen; Turkka Kirjavainen
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

10.  Narcolepsy with cataplexy after A/H1N1 vaccination - A case reported from Cuba.

Authors:  Yaimi Rosales Mesa; Miguel Gonçalves Meira E Cruz
Journal:  Sleep Sci       Date:  2014-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.